23nd Annual MCI Symposium and
Public Education Forum
April 25, 2025/May 2, 2025
Presented by The Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center and 1Florida ADRC
ACCESS INFORMATION
The event will be accessible through the individual Zoom link provided upon registration. This link should arrive upon registration, and will repeat the day before and an hour before the start time.
Please ensure you have included our email address (meetings@worldeventsforum.com) in your “safe senders” list and always check your spam folder for any of our messages! If not found there either, please contact our secretariat so we can manually re-issue this information.
Review the recordings of the 22nd Symposium and Forum
The 23nd Annual MCI Symposium
presented by
The Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, 1FLORIDA Alzheimer’s Disease Research Center and the University of Florida
About the virtual event
INTERACTIVE EVENT
The 2025 edition of the Symposium will be held online in a virtual structure, i.e., consisting of live presentations combined with Q&A sessions as well as panel discussions.
Within three sessions, the Symposium will include three keynotes and several lectures, featuring international experts in the fields of neurology, psychiatry, geriatrics, neuropsychology, radiology, epidemiology, pathology and molecular biology. The presentations will be prerecorded and played during the live sessions, allowing the presenters to respond to incoming questions in writing. The Q&A segments concluding each lecture and the panel discussion at the end of each session will be live, showcasing the video cameras of each presenter, chair and moderator.
The panel discussions will be conducted by the chair who will facilitate the interaction with the audience towards a better understanding of the issues.
3
Keynotes
12
Lectures
1
Public Educational Forum
Q&A
CME/CE
Accredited
2025 MCI PROGRAM COMMITTEE
Melissa Armstrong, PhD, University of Florida
Dr. Melissa Armstrong, MD, MSc, is the Director of the UF Health Mangurian Clinical-Research Headquarters for Lewy Body Dementia at the Norman Fixel Institute for Neurological Diseases.
She earned her medical degree from Loyola University Chicago Stritch School of Medicine, where she also completed her neurology residency. Following her residency, she pursued a movement disorders fellowship at Toronto Western Hospital and obtained a Master of Science in clinical epidemiology and healthcare research from the University of Toronto, both in 2011.
Dr. Armstrong specializes in conditions within the Parkinson’s disease family, including Parkinson’s disease, Lewy body dementia, and atypical parkinsonisms such as corticobasal syndrome, progressive supranuclear palsy, and multiple system atrophy. She is dedicated to a patient-centered approach, working closely with individuals and their families to tailor treatment strategies that align with their personal goals and support network. While there is no cure for these conditions, she employs a combination of medications, non-drug therapies, and multidisciplinary support to enhance quality of life.
In addition to her clinical work, Dr. Armstrong leads research at the LBD Life Lab, focusing on the lived experiences of individuals with parkinsonisms and dementia, as well as their care partners and caregivers. Supported by funding from the National Institutes of Health (NIH) and the Florida Department of Health, her research explores various aspects of Lewy body dementia, including hospitalization outcomes, diagnostic and treatment advancements, clinician-patient communication, and the priorities of those affected by the disease. She also studies the moderate-to-advanced stages of dementia with Lewy bodies to improve care strategies for patients and families.
Beyond her clinical and research commitments, Dr. Armstrong serves as the Associate Chair of Faculty Development for the Department of Neurology at the University of Florida.
Rosie Curiel Cid, PsyD, University of Miami
Dr. Rosie Curiel is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and faculty member of the Center on Aging. As a geriatric neuropsychologist, she has an expertise in the assessment of neurodegenerative conditions among elders. Dr. Curiel is Principal Investigator of a study entitled: Precision-based Computerized Assessment for the Detection of MCI in Older Adults, and is an active Co-investigator on various state and federally funded longitudinal Alzheimer’s disease studies including the 1Florida Alzheimer’s Disease Research Center.
Her program of research focuses on the development of novel and cross-culturally applicable cognitive assessment paradigms. She and her team have generated promising pilot data that these novel cognitive outcome measures are sensitive enough to detect subtle deficits specific to preclinical Alzheimer’s disease, and are highly associated with biological markers of early AD pathology. Her program of research focuses on technologically enhancing these innovative cognitive paradigms into user-friendly clinical outcome measures with the goal of advancing cognitive assessment efforts in clinical trials targeting preclinical AD.
Mary Ganguli, MD, MPH, University of Pittsburgh
Dr. Mary Ganguli is a Professor of Psychiatry, Epidemiology, and Neurology at the University of Pittsburgh. She earned her medical degree from Christian Medical College in India and a Master of Public Health in Epidemiology from the University of Pittsburgh’s Graduate School of Public Health. Dr. Ganguli completed her general psychiatry training at both Memorial University of Newfoundland and the Western Psychiatric Institute and Clinic of UPMC. She holds board certifications from the American Board of Psychiatry and Neurology in General Psychiatry and Geriatric Psychiatry, as well as from the Royal College of Physicians and Surgeons of Canada in Psychiatry.
For over 35 years, Dr. Ganguli has conducted seminal research on the epidemiology of the aging brain and late-life mental disorders, particularly cognitive impairment and dementia. Her work has been continuously funded by the National Institute on Aging since 1986, significantly contributing to the understanding of the origins and progression of these disorders and informing the development of improved treatment strategies for the elderly.
In recognition of her significant scientific contributions, Dr. Ganguli received the 2017 Distinguished Alumni Award for Research from the University of Pittsburgh Graduate School of Public Health. Additionally, in 2019, she was honored with the Distinguished Scientist Award by the American Association for Geriatric Psychiatry for her outstanding research and mentorship in the field of geriatric psychiatry.
David Loewenstein, PhD, University of Miami
Dr. David Loewenstein has had continuous NIH grant funding for over 30 years. He is Principal Investigator on several large NIH and state funded grants and has a number of ongoing longitudinal investigations nationally and internationally with new cognitive instruments developed in his laboratory. The Direct Assessment of Functional status Scale (DAFS) was one of the first performance-based scales for Alzheimer’s disease and has been translated into multiple languages. The Semantic Interference Test (SIT) and the Loewenstein- Acevedo Scales for Semantic Interference and Learning (LASSI-L) have shown considerable promise in the early detection and prediction of progression in patients with early Alzheimer’s disease and other neurodegenerative disorders. Susceptibility to proactive semantic interference (PSI) and most importantly, the failure to recover from semantic interference (frPSI) are extremely sensitive markers of preclinical AD, progression over time and brain biomarkers of amyloid load, tau load, cortical thickness and brain volumetric loss.
Dr. Loewenstein and colleagues have recently made discoveries in the the the areas of failures of inhibitory control and unbinding of previously learned semantic associations. Dr. Loewenstein’s directs the Center for Cognitive Neuroscience and Aging and works with many departments across the UM and numerous medical schools and Universities across the United States and abroad.
Roger McIntosh, PhD, University of Miami
Dr. Roger C. McIntosh is an Associate Professor in the Department of Psychology at the University of Miami, specializing in health psychology. He earned his Ph.D. in Experimental Psychology from Florida Atlantic University in 2012, following a Master of Arts in Psychology from the same institution in 2010. He also holds a Master of Science in Education from Nova Southeastern University (2005) and a Bachelor of Science in Biology from Jacksonville University (2002).
Dr. McIntosh’s research focuses on the psychosocial determinants of immunosuppression and cardiovascular disease in older adults. His work examines risk factors associated with accelerated cognitive aging in chronic disease populations, with a particular emphasis on how cognitive-emotional impairment impacts disease management among individuals living with HIV.
In addition to his research, Dr. McIntosh is a Public Voices Fellow of the OpEd Project, contributing to public discourse on health psychology topics.
Tanja Rundek, MD, PhD, University of Miami
Dr. Tatjana Rundek is a Professor of Neurology, Executive Vice Chair of Research and Faculty Affairs and Director of Clinical Translational Research Division in the Department of Neurology of the University of Miami Miller School of Medicine. She is Scientific Director of the Evelyn F. McKnight Brain Institute at the University of Miami. She is also Director of a Master of Science degree in Clinical Translational Investigation and Director of the KL2 mentored career development research training program at the Miami Clinical Translational Science Institute.
Dr. Rundek is a vascular neurologist, clinical researcher and a leader of several NIH-funded projects and programs on determinants of stroke, age-related memory loss and cognitive decline, and brain health. Dr. Rundek completed a neurology and research fellowship at Columbia University in the City of New York. Dr. Rundek was the first Fulbright Scholar at the Neurological Institute of Columbia University, NY.
Dr. Rundek is a productive and collaborative investigator with over 500 peer reviewed publications, editorials, and book chapters. She has extensive research collaborations with multiple national and international research teams, including investigators from Columbia University on large NIH-funded population-based studies of age-related neurovascular disease (NOMAS, INVEST, CABLE, PHPT, eMERGE) and Albert Einstein in the Bronx (Einstein Aging Study) on vascular cognitive decline and dementia. She serves as a team scientist-leader of large international stroke and aging projects and consortia including NIA Precision Aging Network.
Dr. Rundek is a dedicated clinician scientist, educator, and mentor, who continues to lead local and national research, educational and mentorship programs. She serves as Training Director of two large NINDS-funded clinical trial networks, StrokeNet and NeuroNEXT, and of NIA OneFL Alzheimer’s Disease Research Center (1FL ADRC). She was a recipient of an AHA Mentor award and an NIH K24 research training and career development grant.
Dr. Rundek has been an active member of a broader scientific community. She is a Section Editor of Stroke for Brain Health and serves on the Editorial Boards of several influential scientific journals including Neurology, Journal of Ultrasound in Medicine, and Cerebrovascular Diseases. She also serves on the NIH and other professional organization review study sections. She is a fellow of the American Heart Association (AHA). She is currently President of the Intersocietal Accreditation Commission (IAC) Vascular Testing Board of Directors, a US organization that accredits clinical nuclear/PET, MRI, CT, ultrasound, and carotid stenting programs. She is Immediate Past President of the Neurosonology Communities of Practice of the American Institute in Ultrasound in Medicine, the largest professional medical ultrasound organization in the US. In Florida, Dr. Rundek serves on the AHA South Florida Board and is a recipient of the prestigious AHA Cor Vitae for Stroke Award, In the Company of Women- Outstanding Woman in Science and Technology Miami-Dade award, and the Women in Academic Medicine Career Achievement Award.
Glenn Smith, PhD, University of Florida
Dr. Glenn E. Smith is a Professor in the Department of Clinical and Health Psychology at the University of Florida. He currently serves as contact PI of the 1Florida Alzheimer’s Disease Research Center. He served as department chair from 2015-2021. He is Professor Emeritus of Psychology at the Mayo Clinic College of Medicine. A board-certified neuropsychologist, Dr. Smith has been a practicing clinician for over 30 years and has authored or co-authored over 250 original articles, 14 book chapters, and 2 books on the neuropsychology of cognitive aging and dementia.
Idaly Velez Uribe, PhD, Mount Sinai Medical Center
Dr. Idaly Velez-Uribe received a Ph.D. in Experimental Psychology with an emphasis and concentration in Neuropsychology at Florida Atlantic University. She is currently doing postdoctoral fellow training in neurocognitive measures at FAU and the Wein Center for Alzheimer’s Disease at Mount Sinai Medical within the 1Florida Alzheimer’s Disease Research Center. Her research is focused on how diverse factors influence brain plasticity across the lifespan. She seeks to investigate how variables such as bilingualism, biculturalism, ethnicity, and immigration interact with biology and other environmental factors and influence brain biomarkers, cognition, and behavior and whether that influence extends through an individual’s lifespan to the point of altering the course of neurodegeneration in aging, especially in culturally diverse populations. She has also analyzed brain differences in the comprehension and expression of emotions between the two languages of bilingual individuals using electroencephalographic measures.
COUNTDOWN TO THE SYMPOSIUM
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Resources
Events at A Glance

23nd ANNUAL MILD COGNITIVE IMPAIRMENT SYMPOSIUM
Friday, April 25, 2025
(9:00 am – 4:45 pm US Eastern Time)

THE ANNUAL ALZHEIMER’S PUBLIC EDUCATIONAL FORUM
Friday, May 2, 2025
(10:00 am – 1:00 pm US Eastern Time)
Subscribe